DePuy Synthes Archives - Page 2 of 4 - Medical Design Sourcing

The 10 largest orthopedic device companies in the world

Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet top the list of largest orthopedic device companies. [Adobe Stock image]With elective procedure numbers rebounded after the darkest days of the COVID-19 pandemic, most of the world’s largest orthopedic device companies saw their revenues increase by double-digit percentages during their most recent fiscal years.

Here are the world’s 10 largest orthopedic device companies, ranked by ortho business revenue pulled from their most recent annual reports:

Largest orthopedic device companies Annual revenue (% change) Headquarters 1 Stryker $17.1 billion (+19.2%) Kalamazoo, Michigan 2 Johnson & Johnson – DePuy Synthes $8.6 billion (+10.6%) Locations: Raynham, Massachusetts.; West Chester, Pennsylvania; Warsaw, Indiana; Palm Beach Gardens, Florida 3 Zimmer Biomet (minus ZimVie spinoff) $6.8 billion (+11.6%) Warsaw, Indiana 4 Medtronic – Cranial & Spinal Technologies $4.5 billion (+3.9%) Locat…

FDA clears DePuy Synthes’ Inhance for total shoulder arthroplasty

Johnson & Johnson MedTech’s DePuy Synthes ortho device company announced today that its Inhance system has received FDA clearance for total shoulder arthroplasty.

DePuy Synthes officials say their company is first to market with a fully convertible should arthroplasty system. The new clearance is in addition to the system’s already cleared use in anatomic shoulder arthroplasty and provides surgeons with interoperative flexibility.

The reverse system’s features include:

A 135° neck-shaft angle with lateralized options; A variety of sizing options; 3D laser-printed R/SPEED baseplates and modular Baseplates with central screw and central post options Advanced cross-linked Vitamin E polyethylene for desired wear characteristics and oxidative stability One Step Prep glenoid reamers

“The Inhance shoulder system can be used for an anatomic or reverse shoulder procedure offering the surgeon and OR staff a streamlined and effective shoulder syst…

Thanks, mom! Medtech leaders reflect on Mother’s Day

[Photo from Aditya Romansa on Unsplash]Everyone has a story about how they got into medtech, and it’s no surprise that many of those stories start with how we were raised.

As Mother’s Day approaches, Medical Design & Outsourcing asked medtech leaders to share some thoughts about how their moms inspired their careers, the products they make and the companies they’ve built.

We can never say “thanks” often enough to truly show our gratitude – but one more time can’t hurt.

Get the full story at our sister site, Medical Design & Outsourcing.

How Johnson & Johnson’s DePuy Synthes is shifting toward digital

Johnson & Johnson is increasingly digitizing in the medical device space, with the company even recently rebranding the business to Johnson & Johnson MedTech to reflect the shift.

Many medtech companies have embraced the trend. It’s all about providing software, knowledge and insights to boost healthcare outcomes and hopefully help the system operate more efficiently — versus simply providing devices.

Not only is J&J transforming in-house, but it’s engaging in M&A to boost its offerings. MedTech’s EVP Ashley McEvoy said during the company’s Q1 earnings call: “We’re going to continue to do tuck-ins and to really digitize the patient experience.”

Come to DeviceTalks Boston, May 10-11, 2022, and hear a panel of top officials from J&J’s DePuy Synthes discuss how the company is evolving.

They’ll discuss how DePuy Synthes is changing its product development process, setting up a s…

How medtech is tackling supply chain challenges

A host of medical device companies with manufacturing in Puerto Rico found their supply chains impacted by Hurricane Maria in 2017. It was a harbinger of what was to come. [Image is public domain]Join us at DeviceTalks Boston on May 10-11 to hear how medical device companies are propping open supply lines and ensuring a steady flow of products to customers in a constantly changing world.

Sharing best practices is more important than ever because supply chain challenges aren’t expected to diminish post-pandemic. That’s because superstorms, fires, droughts and other extreme events driven by climate change are already straining the industry’s supply chain — and it could get a lot worse.

(Go to DeviceTalks Boston’s site to register!)

Over the two-day meeting we’ll hear how companies large and small are adapting to new demands, including:

How Viant and Vapotherm combined forces to meet unforeseen demands brought on by the COVID-19 pandemi…

New CEO and CFO take over at bone-cutting robot maker AOT

AOT CEO Elmar Zurbriggen (right) and CFO Peter Oprandi with the company’s CARLO system [Photo courtesy of AOT]Advanced Osteotomy Tools (AOT) announced that Elmar Zurbriggen will become CEO and Peter Oprandi will become CFO effective tomorrow.

Basel, Switzerland-based AOT developed the world’s first certified surgical device to cut bone with a laser. The system is called CARLO, for Cold Ablation Robot-guided Laser Osteotome.

“Elmar and Peter have both gained decades of experience as senior managers in the life science sector, working for global market leaders such as Johnson & Johnson, DePuy Synthes, AstraZeneca and Lonza,” AOT Chair Dr. Erich Platzer said in a news release. “We are delighted that they are now supporting AOT as CEO and CFO. Our goal is to improve patient care with innovative high-tech products. Elmar and Peter are exactly the right leaders for this.”

Get the full story at our sister site, Medical Design & Outsourcing.

New CEO and CFO take over at bone-cutting robot maker AOT

AOT CEO Elmar Zurbriggen (right) and CFO Peter Oprandi with the company’s CARLO system [Photo courtesy of AOT]

Advanced Osteotomy Tools (AOT) announced that Elmar Zurbriggen will become CEO and Peter Oprandi will become CFO effective tomorrow.

Basel, Switzerland-based AOT developed the world’s first certified surgical device to cut bone with a laser. The system is called CARLO, for Cold Ablation Robot-guided Laser Osteotome.

“Elmar and Peter have both gained decades of experience as senior managers in the life science sector, working for global market leaders such as Johnson & Johnson, Depuy Synthes, AstraZeneca and Lonza,” AOT Chair Dr. Erich Platzer said in a news release. “We are delighted that they are now supporting AOT as CEO and CFO. Our goal is to improve patient care with innovative high-tech products. Elmar and Peter are exactly the right leaders for this.” Read more

DePuy Synthes adds two knee systems to Attune Knee portfolio

Attune Cementless Fixed Bearing knee and Attune Medial Stabilized knee [Images courtesy of DePuy Synthes]Johnson & Johnson MedTech announced that its orthopedics company DePuy Synthes has added Cementless Fixed Bearing knee and Medial Stabilized knee to its Attune Knee portfolio.

The company’s two new innovations build on Attune’s kinematic features that include Gradius Curve and Glideright Articulation. Both knee additions work seamlessly with DePuy Synthes’ Velys robotic-assisted surgical system.

“Through our DePuy Synthes knee solutions, we’re revolutionizing the traditional approach to total knee arthroplasty by offering patients a tailored surgical experience based on the combination of our kinematically advanced implants, our differentiated digital technology, and patient-specific techniques,” Juston Gates, worldwide VP of knee reconstruction for DePuy Synthes, said in a news release. “We believe that this combin…

Surgeon wins $20M verdict against Johnson and Johnson’s DePuy Synthes

A federal jury hit DePuy Synthes with a $20 million verdict payable to a surgeon who said the Johnson & Johnson (NYSE:JNJ) orthopedic unit stole his patented technology.

The surgeon, Dr. Gary Lynn Rasmussen of Utah, invented a device for aligning and positioning the prosthesis in knee replacement procedures, according to court records.

He applied for patent protection and pitched the device to DePuy over the following years, including demonstrations, but could not convince them to license the technology.

Get the full story at our sister site, Medical Design & Outsourcing.

Surgeon wins $20M verdict against Johnson and Johnson’s DePuy Synthes

A federal jury hit DePuy Synthes with a $20 million verdict payable to a surgeon who said the Johnson & Johnson (NYSE: JNJ) orthopedic unit stole his patented technology.

The surgeon, Dr. Gary Lynn Rasmussen of Utah, invented a device for aligning and positioning the prothesis in knee replacement procedures, according to court records. He applied for patent protection and pitched the device to DePuy over the following years, including demonstrations, but could not convince them to license the technology.

Rasmussen, represented by lawyers at Fish & Richardson, sued in 2020, saying DePuy’s Attune Knee System included a product called a Balanced Sizer for adjusting the tension of ligaments in a knee joint to position and fit the prothesis, in violation of his patents.

DePuy, represented by lawyers at Jones Day, denied wrongdoing.

Following trial, a jury decided yesterday that DePuy willfully violated one of the two patents with its Bala…

DeviceTalks Boston returns with a unique approach for medtech connections and development

DeviceTalks Boston speakers include Meghan Scanlon, senior vice president at Boston Scientific and president of its urology and pelvic health business. [Photo courtesy of Boston Scientific]

A few months back, I wrote what was best described by a colleague as a “salty” column in which I demanded conference organizers like myself step up our game if we expect to bring back attendees.

“For too long, conference organizers have relied upon a potent cocktail of FOMO and habit,” I wrote in one particularly briny portion. “Sure, organizers try to amp up content, introduce cool partnering apps and a few gimmicks. (One recent healthcare meeting had puppies, actual puppies … gimmicky, but intriguing.)”

Here I am, four months later, and I still agree with me!

We’ve been working harder — and smarter — to assemble the agenda of DeviceTalks Boston, coming up May 10…

How a robot revolution will reduce the physical burdens of orthopedic surgery

[Image courtesy of Depuy Synthes/Johnson & Johnson]DePuy Synthes Worldwide President of Joint Reconstruction Andrew Ekdahl thinks robotic-assisted systems will be a big help for orthopedic surgeons who are busier than ever.

Innovations in surgical instruments and capabilities have substantially increased the volume of procedures being performed on any given day — and increased the physical burden on orthopedic surgeons.

Many years ago, the busiest surgeons would conduct three orthopedic procedures per week, said Andrew Ekdahl, worldwide president of joint reconstruction at DePuy Synthes. But now those busiest surgeons are performing more than nine procedures per day, multiple days each week.

Get the full story on our sister site, Medical Design & Outsourcing.